Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Keller CEO to undergo medical treatment, will stay in role

15th May 2025 12:14

Keller Group PLC - London-headquartered geotechnical engineering company - Chief Executive Officer Michael Speakman "will be undergoing necessary medical treatment", but will continue in his role supported by Non-Executive Chair Carl-Peter Forster, the executive committee and Chief Financial Officer David Burke.

"Michael will remain actively engaged in key strategic decisions and day-to-day leadership," Keller Group says. "The board and the entire company are fully supportive of Michael during this period."

Current stock price: 1,558.00 pence

12-month change: up 13%

By Emma Curzon, Alliance News reporter

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

Keller
FTSE 100 Latest
Value8,684.56
Change50.81